COVID Boosters Should Target Omicron BA.4/5
An FDA vaccine advisory committee recommended future COVID-19 vaccine boosters should include a SARS-CoV-2 omicron BA.4/5 component for boosters beginning in fall 2022.
An FDA vaccine advisory committee recommended future COVID-19 vaccine boosters should include a SARS-CoV-2 omicron BA.4/5 component for boosters beginning in fall 2022.
The FDA has expanded the approval for Merck's Vaxneuvance for prevention of invasive disease caused by Streptococcus pneumoniae to include children 6 weeks through 17 years of age.
One of the chief responsibilities of pulmonologists and respiratory therapists is to administer and monitor supplemental oxygen therapy.
Philips Respironics is recalling all V60 and V60 Plus ventilators because an internal power fluctuation may cause the ventilator to shut down unintentionally either with or without any visible or audible alarms, according to an FDA recall alert.
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.
Even though demand for COVID-19 tests greatly overwhelmed supply earlier in the pandemic, rapid home tests are more available today.
Dale Medical Products has introduced its new BreezeLock Endotracheal Tube Holder, featuring a soft, comfortable, flexible neckband with no hard plastic parts.